Pfizer Receives Positive FDA Advisory Committee Votes Supporting Potential Approval for Vaccine Candidate to Help Combat RSV in Older AdultsBusiness Wire • 02/28/23
FDA advisors recommend Pfizer RSV vaccine for older adults, despite possible Guillain-Barre risksCNBC • 02/28/23
Seagen stock rises as Pfizer reportedly in talks to acquire Seattle-area biotech giantGeekWire • 02/27/23
'Here We Go Again': Seagen Soars As Pfizer Reportedly Mulls A TakeoverInvestors Business Daily • 02/27/23
Seagen's stock surges 15% after a report that Pfizer is in talks to buy the cancer-focused biotechBusiness Insider • 02/27/23
Seagen's stock soars on reported Pfizer buyout interest; Union Pacific shares rally after CEO ousterMarket Watch • 02/27/23
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adultsCNBC • 02/24/23
First RSV Vaccine For Kids—Given To Pregnant Moms—Could Arrive Months Early As FDA Fast-Tracks ReviewForbes • 02/21/23